Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03195114 · ClinicalTrials.gov registry record
Cardiac MRI for Post-TAVR Paravalvular Leak Assessment
A clinical trial, sponsored by University of Pittsburgh.
- Completed
- Registry status
- 15
- Enrollment target
NCT03195114 is a clinical trial that has completed, run by University of Pittsburgh. The registered enrollment target is 15 participants.
The verdict
NCT03195114 has completed, sponsored by University of Pittsburgh.
- COMPLETED
- Registry status
- 15 participants
- Enrollment target
Study Summary
The objectives of this study are to: a) evaluate and correlate the severity of paravalvular leak (PVL) assessed by both cardiac MRI and transthoracic echocardiography (TTE) after transcatheter aortic valve replacement (TAVR) with Medtronic Evolut-R or Evolut PRO bioprostheses; b) assess the inter and intraobserver variability of both imaging methods; and c) correlate the severity of PVL with post-TAVR changes in LV remodeling and clinical outcomes.
Interventions
- DIAGNOSTIC_TEST Multimodality Imaging and Biomarkers
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 15 participants |
| Start Date | 2017-01-01 |
| Est. Completion | 2019-02-15 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03195114
The ClinicalTrials.gov registry entry for NCT03195114 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 15 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Pittsburgh, which has 1,238 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Multimodality Imaging and Biomarkers is the first listed.
NCT03195114 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03195114 about?
NCT03195114 is a clinical study titled "Cardiac MRI for Post-TAVR Paravalvular Leak Assessment". The objectives of this study are to: a) evaluate and correlate the severity of paravalvular leak (PVL) assessed by both cardiac MRI and transthoracic echocardiography (TTE) after transcatheter aortic valve replacement (TAVR) with Medtronic Evolut-R or Evolut PRO bioprostheses; b) assess the inter an...
What is the current status of trial NCT03195114?
This trial is currently completed. The enrollment target is 15 participants. The study started on 2017-01-01. Estimated completion is 2019-02-15.
What interventions are being tested in trial NCT03195114?
The interventions under investigation include: Multimodality Imaging and Biomarkers (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT03195114?
This trial is sponsored by University of Pittsburgh, which has 1,238 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.